Skip to content

H.R. 1266 · 119th Congress (2025–2027)

Combating Illicit Xylazine Act

This bill regulates xylazine under the Controlled Substances Act (CSA).

Xylazine, also known as tranq, is a nonopioid sedative and pain reliever that is approved for use in animals. Recently, the Drug Enforcement Administration (DEA) has reported an increase in trafficking of fentanyl mixed with xylazine.

This bill adds xylazine, including its salts, isomers, and salts of isomers, to schedule III of the CSA. Schedule III controlled substances, including anabolic steroids, buprenorphine, and ketamine, have less potential for abuse than a schedule I or II substance, have a currently accepted medical use, and have low or moderate risk of dependence if abused.

Under the bill, manufacturing, distributing, or dispensing xylazine, or possessing with intent to manufacture, distribute, or dispense xylazine for illicit use is subject to criminal penalties under the CSA. The bill also requires xylazine transactions to be tracked in the drug reporting system maintained by the DEA.

The bill exempts from registration under the CSA persons and entities that possess xylazine (1) lawfully dispensed by a veterinarian or pharmacy and (2) for an animal or for use in certain animal-control or wildlife programs.

The bill also exempts xylazine manufacturers from the CSA's physical security requirements.

Finally, the bill requires the DEA, in coordination with the Food and Drug Administration, to report on (1) the prevalence and impact of illicit xylazine use in the United States, and (2) updated information on the prevalence and proliferation of xylazine trafficking and misuse in the United States.

Show official title

To prohibit certain uses of xylazine, and for other purposes.

Passed House

This bill’s path

580 days after it was introduced

This is H.R. 1266’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced19 months

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Jimmy Panetta (D-CA-19)
Cosponsors
114 cosponsors

35 original · 79 later

63 R · 51 D

  1. Rep. Stephanie I. Bice (R-OK-5)· Original · Feb 12, 2025
  2. Rep. Gus M. Bilirakis (R-FL-12)· Original · Feb 12, 2025
  3. Rep. Don Bacon (R-NE-2)· Original · Feb 12, 2025
  4. Rep. Nanette Diaz Barragán (D-CA-44)· Original · Feb 12, 2025
  5. Rep. Troy Balderson (R-OH-12)· Original · Feb 12, 2025
  6. Rep. Tim Burchett (R-TN-2)· Original · Feb 12, 2025
  7. Rep. Jim Costa (D-CA-21)· Original · Feb 12, 2025
  8. Rep. Yvette D. Clarke (D-NY-9)· Original · Feb 12, 2025
  9. Rep. Steve Cohen (D-TN-9)· Original · Feb 12, 2025
  10. Rep. J. Luis Correa (D-CA-46)· Original · Feb 12, 2025
  11. Rep. Angie Craig (D-MN-2)· Original · Feb 12, 2025
  12. Rep. Dan Crenshaw (R-TX-2)· Original · Feb 12, 2025
  13. Rep. Mike Carey (R-OH-15)· Original · Feb 12, 2025
  14. Rep. Mike Collins (R-GA-10)· Original · Feb 12, 2025
  15. Rep. Juan Ciscomani (R-AZ-6)· Original · Feb 12, 2025
  16. Rep. Donald G. Davis (D-NC-1)· Original · Feb 12, 2025
  17. Rep. Christopher R. Deluzio (D-PA-17)· Original · Feb 12, 2025
  18. Rep. Suzan K. DelBene (D-WA-1)· Original · Feb 12, 2025
  19. Rep. Madeleine Dean (D-PA-4)· Original · Feb 12, 2025
  20. Rep. Brian K. Fitzpatrick (R-PA-1)· Original · Feb 12, 2025
  21. Rep. Scott Fitzgerald (R-WI-5)· Original · Feb 12, 2025
  22. Rep. Vince Fong (R-CA-20)· Original · Feb 12, 2025
  23. Rep. Diana Harshbarger (R-TN-1)· Original · Feb 12, 2025
  24. Rep. Josh Harder (D-CA-9)· Original · Feb 12, 2025
  25. Rep. Mariannette Miller-Meeks (R-IA-1)· Original · Feb 12, 2025
  26. Rep. Seth Magaziner (D-RI-2)· Original · Feb 12, 2025
  27. Rep. Donald Norcross (D-NJ-1)· Original · Feb 12, 2025
  28. Rep. Jay Obernolte (R-CA-23)· Original · Feb 12, 2025
  29. Rep. August Pfluger (R-TX-11)· Original · Feb 12, 2025
  30. Rep. Chris Pappas (D-NH-1)· Original · Feb 12, 2025
  31. Rep. Brittany Pettersen (D-CO-7)· Original · Feb 12, 2025
  32. Rep. Deborah K. Ross (D-NC-2)· Original · Feb 12, 2025
  33. Rep. Thomas R. Suozzi (D-NY-3)· Original · Feb 12, 2025
  34. Rep. Claudia Tenney (R-NY-24)· Original · Feb 12, 2025
  35. Rep. Daniel Webster (R-FL-11)· Original · Feb 12, 2025
  36. Rep. Laurel M. Lee (R-FL-15)· Later · Feb 14, 2025
  37. Rep. Tracey Mann (R-KS-1)· Later · Feb 14, 2025
  38. Rep. Darren Soto (D-FL-9)· Later · Feb 14, 2025
  39. Rep. Andrea Salinas (D-OR-6)· Later · Feb 14, 2025
  40. Rep. Robert J. Wittman (R-VA-1)· Later · Feb 14, 2025
  41. Rep. Sheila Cherfilus-McCormick (D-FL-20)· Later · Feb 24, 2025
  42. Rep. Mike Haridopolos (R-FL-8)· Later · Feb 24, 2025
  43. Rep. Michael A. Rulli (R-OH-6)· Later · Feb 24, 2025
  44. Rep. Terri A. Sewell (D-AL-7)· Later · Feb 24, 2025
  45. Rep. Sharice Davids (D-KS-3)· Later · Feb 25, 2025
  46. Rep. Brad Finstad (R-MN-1)· Later · Feb 25, 2025
  47. Rep. Rudy Yakym III (R-IN-2)· Later · Feb 25, 2025
  48. Rep. Ken Calvert (R-CA-41)· Later · Mar 3, 2025
  49. Rep. Andy Harris (R-MD-1)· Later · Mar 3, 2025
  50. Rep. Dusty Johnson (R-SD)· Later · Mar 3, 2025
  51. Rep. Keith Self (R-TX-3)· Later · Mar 3, 2025
  52. Rep. Robin L. Kelly (D-IL-2)· Later · Mar 5, 2025
  53. Rep. Bryan Steil (R-WI-1)· Later · Mar 5, 2025
  54. Rep. Eugene Simon Vindman (D-VA-7)· Later · Mar 25, 2025
  55. Rep. Addison P. McDowell (R-NC-6)· Later · Mar 31, 2025
  56. Rep. Eric Sorensen (D-IL-17)· Later · Apr 24, 2025
  57. Rep. Jake Auchincloss (D-MA-4)· Later · May 29, 2025
  58. Rep. Jefferson Van Drew (R-NJ-2)· Later · Jun 12, 2025
  59. Rep. Brad Knott (R-NC-13)· Later · Jul 14, 2025
  60. Rep. Christopher H. Smith (R-NJ-4)· Later · Jul 17, 2025
  61. Rep. Mike Thompson (D-CA-4)· Later · Jul 17, 2025
  62. Res. Comm. Pablo José Hernández (D-PR)· Later · Jul 21, 2025
  63. Rep. David Rouzer (R-NC-7)· Later · Jul 21, 2025
  64. Rep. Michael K. Simpson (R-ID-2)· Later · Jul 21, 2025
  65. Rep. Jill N. Tokuda (D-HI-2)· Later · Jul 23, 2025
  66. Rep. Glenn Grothman (R-WI-6)· Later · Jul 29, 2025
  67. Rep. Adam Gray (D-CA-13)· Later · Jul 29, 2025
  68. Rep. Cliff Bentz (R-OR-2)· Later · Aug 1, 2025
  69. Rep. Dave Min (D-CA-47)· Later · Aug 12, 2025
  70. Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · Aug 15, 2025
  71. Rep. James R. Baird (R-IN-4)· Later · Aug 19, 2025
  72. Rep. Julia Letlow (R-LA-5)· Later · Aug 19, 2025
  73. Rep. Hillary J. Scholten (D-MI-3)· Later · Aug 29, 2025
  74. Rep. Young Kim (R-CA-40)· Later · Sep 2, 2025
  75. Rep. Beth Van Duyne (R-TX-24)· Later · Sep 8, 2025
  76. Rep. Kristen McDonald Rivet (D-MI-8)· Later · Sep 9, 2025
  77. Rep. Troy E. Nehls (R-TX-22)· Later · Sep 9, 2025
  78. Rep. Zachary Nunn (R-IA-3)· Later · Sep 9, 2025
  79. Rep. Derrick Van Orden (R-WI-3)· Later · Sep 9, 2025
  80. Rep. Randy K. Weber, Sr. (R-TX-14)· Later · Sep 9, 2025
  81. Rep. Nikki Budzinski (D-IL-13)· Later · Sep 10, 2025
  82. Rep. Sarah McBride (D-DE)· Later · Sep 11, 2025
  83. Rep. Frank D. Lucas (R-OK-3)· Later · Sep 15, 2025
  84. Rep. Ronny Jackson (R-TX-13)· Later · Sep 19, 2025
  85. Rep. Michelle Fischbach (R-MN-7)· Later · Sep 26, 2025
  86. Rep. Timothy M. Kennedy (D-NY-26)· Later · Sep 30, 2025
  87. Rep. Gabe Evans (R-CO-8)· Later · Oct 17, 2025
  88. Rep. Kim Schrier (D-WA-8)· Later · Oct 17, 2025
  89. Rep. Derek Schmidt (R-KS-2)· Later · Oct 17, 2025
  90. Rep. Zoe Lofgren (D-CA-18)· Later · Dec 4, 2025
  91. Rep. Josh Riley (D-NY-19)· Later · Dec 9, 2025
  92. Rep. John Garamendi (D-CA-8)· Later · Dec 17, 2025
  93. Rep. Gabe Vasquez (D-NM-2)· Later · Jan 6, 2026
  94. Rep. Marie Gluesenkamp Perez (D-WA-3)· Later · Jan 7, 2026
  95. Rep. Scott DesJarlais (R-TN-4)· Later · Feb 9, 2026
  96. Rep. Glenn Ivey (D-MD-4)· Later · Feb 11, 2026
  97. Rep. Jack Bergman (R-MI-1)· Later · Feb 24, 2026
  98. Rep. Valerie P. Foushee (D-NC-4)· Later · Feb 26, 2026
  99. Rep. Mark Alford (R-MO-4)· Later · Mar 3, 2026
  100. Rep. Nicholas A. Langworthy (R-NY-23)· Later · Mar 20, 2026
  101. Rep. Lori Trahan (D-MA-3)· Later · Mar 26, 2026
  102. Rep. Tim Moore (R-NC-14)· Later · Mar 30, 2026
  103. Rep. Josh Gottheimer (D-NJ-5)· Later · Apr 6, 2026
  104. Rep. Chuck Edwards (R-NC-11)· Later · Apr 16, 2026
  105. Rep. Laura Gillen (D-NY-4)· Later · Apr 27, 2026
  106. Rep. Ryan Mackenzie (R-PA-7)· Later · May 11, 2026
  107. Rep. Sheri Biggs (R-SC-3)· Later · Jun 4, 2026
  108. Rep. John Joyce (R-PA-13)· Later · Jun 18, 2026
  109. Rep. Craig A. Goldman (R-TX-12)· Later · Jun 24, 2026
  110. Rep. Monica De La Cruz (R-TX-15)· Later · Jun 30, 2026
  111. Rep. Scott H. Peters (D-CA-50)· Later · Jun 30, 2026
  112. Rep. Dina Titus (D-NV-1)· Later · Jul 21, 2026
  113. Rep. Maggie Goodlander (D-NH-2)· Later · Aug 24, 2026
  114. Rep. Steven Horsford (D-NV-4)· Later · Sep 14, 2026
Policy area
Crime and Law Enforcement
Subjects
  • Congressional oversight
  • Consumer affairs
  • Criminal procedure and sentencing
  • Drug safety, medical device, and laboratory regulation
  • Drug trafficking and controlled substances
  • Licensing and registrations
  • Manufacturing
  • U.S. Sentencing Commission
  • 1 more
    • Veterinary medicine and animal diseases

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Referred to Health

    Referred to the Subcommittee on Health.

    Sources
  2. Introduced in House

    Document: Introduced in House

    Sources
  3. ▸ 8 committee actions · Feb 12, 2025 – Sep 14, 2026
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held

      Sources
    3. Forwarded by subcommittee

      Forwarded by Subcommittee to Full Committee by Voice Vote.

      Sources
    4. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    5. Markup session held

      Committee Consideration and Mark-up Session Held

      Sources
    6. Ordered reported

      Ordered to be Reported in the Nature of a Substitute by the Yeas and Nays: 48 - 0.

      Sources
    7. Committee discharged

      Committee on the Judiciary discharged.

      Sources
    8. Reported by committee

      Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 119-816, Part I.

      Sources
  4. Latest

    Passed House

    Congressional Record H5671–H5672

    On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.

    The House passed the bill as amended.

    Document: Engrossed in House

    Sources

Committees

  1. HouseEnergy and CommerceReferred Feb 12, 2025 · Markup Jul 20, 2026 · Markup Jul 21, 2026 · Reported Sep 14, 2026H. Rept. 119-816
    1. Jul 20, 2026 · Markup

    2. Jul 1, 2026 · Markup

    1. H. Rept. 119-816 · Sep 14, 2026 · Combating Illicit Xylazine Act
  2. HouseHealthReferred Feb 12, 2025 · Markup Jun 25, 2026 · Reported Jun 25, 2026
    1. Jun 25, 2026 · Markup

    2. Mar 26, 2026 · Hearing

  3. HouseJudiciaryReferred Feb 12, 2025

Floor record

i

Explicit consideration evidence: the measure’s bill-status citation matched a GovInfo title, headline, or first paragraph. Incidental mentions are not listed.

  1. Sep 15, 2026 · House · Considered under suspension of the rulesCongressional Record H5671–H5673

    Combating Illicit Xylazine Act

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Reported in House
Engrossed in House
Placed on Calendar Senate
Titles (2)
  1. Combating Illicit Xylazine Act

    Short title, Display title · Placed on Calendar Senate, Engrossed in House, Reported in House, Introduced in House

  2. To prohibit certain uses of xylazine, and for other purposes.

    Official title · Engrossed in House, Introduced in House